751Indexed trials
canonical disease area
Epilepsy
Intelligence
Epilepsy intelligence: 751 indexed trials, 146 recruiting studies, 405 sponsors across 74 countries.
146Recruiting
405Sponsors
74Countries
Leading sponsors
UCB Pharma220 recruiting
GlaxoSmithKline190 recruiting
National Institute of Neurological Disorders and Stroke (NINDS)141 recruiting
Bial - Portela C S.A.120 recruiting
Hospices Civils de Lyon112 recruiting
Eisai Inc.111 recruiting
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.100 recruiting
Assiut University103 recruiting
Assistance Publique Hopitaux De Marseille104 recruiting
Jazz Pharmaceuticals93 recruiting
NYU Langone Health91 recruiting
Assistance Publique - Hôpitaux de Paris93 recruiting
Geographic activity
United States315trials
France104trials
United Kingdom69trials
Germany60trials
Italy54trials
Spain51trials
China41trials
Canada36trials
Poland33trials
Belgium33trials
Australia33trials
Netherlands27trials
Leading interventions
Levetiracetam23trials
Perampanel11trials
Brivaracetam9trials
Lamotrigine8trials
BIA 2-0938trials
Lacosamide7trials
MRI5trials
phenytoin4trials
Zonisamide4trials
Everolimus4trials
levetiracetam4trials
topiramate4trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.